These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 17596107)
1. Novel genetic techniques and approaches in the microbial genomics era: identification and/or validation of targets for the discovery of new antibacterial agents. Pucci MJ Drugs R D; 2007; 8(4):201-12. PubMed ID: 17596107 [TBL] [Abstract][Full Text] [Related]
2. Use of genomics to select antibacterial targets. Pucci MJ Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986 [TBL] [Abstract][Full Text] [Related]
4. Using genomics to develop novel antibacterial therapeutics. Nagaraj NS; Singh OV Crit Rev Microbiol; 2010 Nov; 36(4):340-8. PubMed ID: 20670176 [TBL] [Abstract][Full Text] [Related]
5. When will the genomics investment pay off for antibacterial discovery? Mills SD Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281 [TBL] [Abstract][Full Text] [Related]
6. Postgenomic strategies in antibacterial drug discovery. Brötz-Oesterhelt H; Sass P Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314 [TBL] [Abstract][Full Text] [Related]
8. Functional genomics in antibacterial drug discovery. Freiberg C; Brötz-Oesterhelt H Drug Discov Today; 2005 Jul; 10(13):927-35. PubMed ID: 15993812 [TBL] [Abstract][Full Text] [Related]
9. Microbial genomics and novel antibiotic discovery: new technology to search for new drugs. Dougherty TJ; Barrett JF; Pucci MJ Curr Pharm Des; 2002; 8(13):1119-35. PubMed ID: 12052223 [TBL] [Abstract][Full Text] [Related]
10. Use of genetic and chemical synthetic lethality as probes of complexity in bacterial cell systems. Klobucar K; Brown ED FEMS Microbiol Rev; 2018 Jan; 42(1):. PubMed ID: 29069427 [TBL] [Abstract][Full Text] [Related]
11. Crystallizing new approaches for antimicrobial drug discovery. Schmid MB Biochem Pharmacol; 2006 Mar; 71(7):1048-56. PubMed ID: 16458857 [TBL] [Abstract][Full Text] [Related]
12. Antibacterial drug discovery in the post-genomics era. Lerner CG; Beutel BA Curr Drug Targets Infect Disord; 2002 Jun; 2(2):109-19. PubMed ID: 12462143 [TBL] [Abstract][Full Text] [Related]
14. The decline of antibiotic era--new approaches for antibacterial drug discovery. Jagusztyn-Krynicka EK; Wyszyńska A Pol J Microbiol; 2008; 57(2):91-8. PubMed ID: 18646395 [TBL] [Abstract][Full Text] [Related]
15. Novel targets for the future development of antibacterial agents. McDevitt D; Payne DJ; Holmes DJ; Rosenberg M Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826 [TBL] [Abstract][Full Text] [Related]
16. Seeing is believing: the impact of structural genomics on antimicrobial drug discovery. Schmid MB Nat Rev Microbiol; 2004 Sep; 2(9):739-46. PubMed ID: 15372084 [TBL] [Abstract][Full Text] [Related]
17. Genomics in anti-infective drug discovery--getting to endgame. Haney SA; Alksne LE; Dunman PM; Murphy E; Projan SJ Curr Pharm Des; 2002; 8(13):1099-118. PubMed ID: 12052222 [TBL] [Abstract][Full Text] [Related]
18. Delivering novel targets and antibiotics from genomics. Payne DJ; Holmes DJ; Rosenberg M Curr Opin Investig Drugs; 2001 Aug; 2(8):1028-34. PubMed ID: 11892909 [TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
20. Antibiotics and the post-genome revolution. Amini S; Tavazoie S Curr Opin Microbiol; 2011 Oct; 14(5):513-8. PubMed ID: 21816663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]